IVD Infectious Diseases Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

IVD Infectious Diseases Market to 2027 - Global Analysis and Forecasts By Product (Instruments, Reagents, Software); Technology (Immunochemistry, Microbiology, Molecular Diagnostics); Application (MRSA, Streptococcus, Clostridium, Vancomycin-resistant enterococci, Carbapenem-resistant Bacteria, Respiratory virus)

Report Code: TIPRE00005215 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
IVD is an important tool in the healthcare systems, providing crucial information for deciding the right medical decisions. IVD infectious diseases includes hepatitis B virus, Hepatitis C virus, HIV, HSV, tuberculosis, measles etc.

MARKET DYNAMICS
The IVD Infectious Diseases market is anticipated to grow in the forecast, owing to the factors such as prevalence of infectious diseases such as cholera, tuberculosis, hepatitis B, HIV etc., growing geriatric population, decreasing immune levels, high population growth, increasing awareness and healthcare structure.

MARKET SCOPE
The "Global IVD Infectious Diseases Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of IVD Infectious Diseases market with detailed market segmentation by Product, Technology, Application and geography. The global IVD Infectious Diseases market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading IVD Infectious Diseases market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global IVD Infectious Diseases market is segmented on the basis of Product, Technology and Application. Based on Product the market is segmented into Instruments, Reagents and Software. Based on Technology the market is segmented into Immunochemistry, Microbiology and Molecular Diagnostics. Based on Application the market is segmented into MRSA, Streptococcus, Clostridium, Vancomycin-resistant enterococci, Carbapenem-resistant Bacteria, Respiratory virus.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global IVD Infectious Diseases market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The IVD Infectious Diseases market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting IVD Infectious Diseases market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the IVD Infectious Diseases market in these regions.

MARKET PLAYERS
The reports cover key developments in the IVD Infectious Diseases market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from IVD Infectious Diseases market are anticipated to lucrative growth opportunities in the future with the rising demand for IVD Infectious Diseases market in the global market. Below mentioned is the list of few companies engaged in the IVD Infectious Diseases market.

The report also includes the profiles of IVD Infectious Diseases market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Roche Diagnostics
  • Abbott Laboratories
  • Alere
  • Hologic, Inc
  • BD
  • Bio-Rad Laboratories
  • Siemens Healthcare
  • bioMeriux SA
  • Luminex Corporation
  • LifeScan, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 IVD Infectious Diseases Market - By Product
1.3.2 IVD Infectious Diseases Market - By Technology
1.3.3 IVD Infectious Diseases Market - By Application
1.3.4 IVD Infectious Diseases Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IVD INFECTIOUS DISEASES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IVD INFECTIOUS DISEASES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IVD INFECTIOUS DISEASES MARKET - GLOBAL MARKET ANALYSIS
6.1. IVD INFECTIOUS DISEASES - GLOBAL MARKET OVERVIEW
6.2. IVD INFECTIOUS DISEASES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. IVD INFECTIOUS DISEASES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis
7.4. REAGENTS
7.4.1. Overview
7.4.2. Reagents Market Forecast and Analysis
7.5. SOFTWARE
7.5.1. Overview
7.5.2. Software Market Forecast and Analysis
8. IVD INFECTIOUS DISEASES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOCHEMISTRY
8.3.1. Overview
8.3.2. Immunochemistry Market Forecast and Analysis
8.4. MICROBIOLOGY
8.4.1. Overview
8.4.2. Microbiology Market Forecast and Analysis
8.5. MOLECULAR DIAGNOSTICS.
8.5.1. Overview
8.5.2. Molecular Diagnostics. Market Forecast and Analysis
9. IVD INFECTIOUS DISEASES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. MRSA
9.3.1. Overview
9.3.2. MRSA Market Forecast and Analysis
9.4. STREPTOCOCCUS
9.4.1. Overview
9.4.2. Streptococcus Market Forecast and Analysis
9.5. CLOSTRIDIUM
9.5.1. Overview
9.5.2. Clostridium Market Forecast and Analysis
9.6. VANCOMYCIN-RESISTANT ENTEROCOCCI
9.6.1. Overview
9.6.2. Vancomycin-resistant enterococci Market Forecast and Analysis
9.7. CARBAPENEM-RESISTANT BACTERIA
9.7.1. Overview
9.7.2. Carbapenem-resistant Bacteria Market Forecast and Analysis
9.8. RESPIRATORY VIRUS
9.8.1. Overview
9.8.2. Respiratory virus Market Forecast and Analysis
10. IVD INFECTIOUS DISEASES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America IVD Infectious Diseases Market Overview
10.1.2 North America IVD Infectious Diseases Market Forecasts and Analysis
10.1.3 North America IVD Infectious Diseases Market Forecasts and Analysis - By Product
10.1.4 North America IVD Infectious Diseases Market Forecasts and Analysis - By Technology
10.1.5 North America IVD Infectious Diseases Market Forecasts and Analysis - By Application
10.1.6 North America IVD Infectious Diseases Market Forecasts and Analysis - By Countries
10.1.6.1 United States IVD Infectious Diseases Market
10.1.6.1.1 United States IVD Infectious Diseases Market by Product
10.1.6.1.2 United States IVD Infectious Diseases Market by Technology
10.1.6.1.3 United States IVD Infectious Diseases Market by Application
10.1.6.2 Canada IVD Infectious Diseases Market
10.1.6.2.1 Canada IVD Infectious Diseases Market by Product
10.1.6.2.2 Canada IVD Infectious Diseases Market by Technology
10.1.6.2.3 Canada IVD Infectious Diseases Market by Application
10.1.6.3 Mexico IVD Infectious Diseases Market
10.1.6.3.1 Mexico IVD Infectious Diseases Market by Product
10.1.6.3.2 Mexico IVD Infectious Diseases Market by Technology
10.1.6.3.3 Mexico IVD Infectious Diseases Market by Application
10.2. EUROPE
10.2.1 Europe IVD Infectious Diseases Market Overview
10.2.2 Europe IVD Infectious Diseases Market Forecasts and Analysis
10.2.3 Europe IVD Infectious Diseases Market Forecasts and Analysis - By Product
10.2.4 Europe IVD Infectious Diseases Market Forecasts and Analysis - By Technology
10.2.5 Europe IVD Infectious Diseases Market Forecasts and Analysis - By Application
10.2.6 Europe IVD Infectious Diseases Market Forecasts and Analysis - By Countries
10.2.6.1 Germany IVD Infectious Diseases Market
10.2.6.1.1 Germany IVD Infectious Diseases Market by Product
10.2.6.1.2 Germany IVD Infectious Diseases Market by Technology
10.2.6.1.3 Germany IVD Infectious Diseases Market by Application
10.2.6.2 France IVD Infectious Diseases Market
10.2.6.2.1 France IVD Infectious Diseases Market by Product
10.2.6.2.2 France IVD Infectious Diseases Market by Technology
10.2.6.2.3 France IVD Infectious Diseases Market by Application
10.2.6.3 Italy IVD Infectious Diseases Market
10.2.6.3.1 Italy IVD Infectious Diseases Market by Product
10.2.6.3.2 Italy IVD Infectious Diseases Market by Technology
10.2.6.3.3 Italy IVD Infectious Diseases Market by Application
10.2.6.4 Spain IVD Infectious Diseases Market
10.2.6.4.1 Spain IVD Infectious Diseases Market by Product
10.2.6.4.2 Spain IVD Infectious Diseases Market by Technology
10.2.6.4.3 Spain IVD Infectious Diseases Market by Application
10.2.6.5 United Kingdom IVD Infectious Diseases Market
10.2.6.5.1 United Kingdom IVD Infectious Diseases Market by Product
10.2.6.5.2 United Kingdom IVD Infectious Diseases Market by Technology
10.2.6.5.3 United Kingdom IVD Infectious Diseases Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific IVD Infectious Diseases Market Overview
10.3.2 Asia-Pacific IVD Infectious Diseases Market Forecasts and Analysis
10.3.3 Asia-Pacific IVD Infectious Diseases Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific IVD Infectious Diseases Market Forecasts and Analysis - By Technology
10.3.5 Asia-Pacific IVD Infectious Diseases Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific IVD Infectious Diseases Market Forecasts and Analysis - By Countries
10.3.6.1 Australia IVD Infectious Diseases Market
10.3.6.1.1 Australia IVD Infectious Diseases Market by Product
10.3.6.1.2 Australia IVD Infectious Diseases Market by Technology
10.3.6.1.3 Australia IVD Infectious Diseases Market by Application
10.3.6.2 China IVD Infectious Diseases Market
10.3.6.2.1 China IVD Infectious Diseases Market by Product
10.3.6.2.2 China IVD Infectious Diseases Market by Technology
10.3.6.2.3 China IVD Infectious Diseases Market by Application
10.3.6.3 India IVD Infectious Diseases Market
10.3.6.3.1 India IVD Infectious Diseases Market by Product
10.3.6.3.2 India IVD Infectious Diseases Market by Technology
10.3.6.3.3 India IVD Infectious Diseases Market by Application
10.3.6.4 Japan IVD Infectious Diseases Market
10.3.6.4.1 Japan IVD Infectious Diseases Market by Product
10.3.6.4.2 Japan IVD Infectious Diseases Market by Technology
10.3.6.4.3 Japan IVD Infectious Diseases Market by Application
10.3.6.5 South Korea IVD Infectious Diseases Market
10.3.6.5.1 South Korea IVD Infectious Diseases Market by Product
10.3.6.5.2 South Korea IVD Infectious Diseases Market by Technology
10.3.6.5.3 South Korea IVD Infectious Diseases Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa IVD Infectious Diseases Market Overview
10.4.2 Middle East and Africa IVD Infectious Diseases Market Forecasts and Analysis
10.4.3 Middle East and Africa IVD Infectious Diseases Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa IVD Infectious Diseases Market Forecasts and Analysis - By Technology
10.4.5 Middle East and Africa IVD Infectious Diseases Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa IVD Infectious Diseases Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa IVD Infectious Diseases Market
10.4.6.1.1 South Africa IVD Infectious Diseases Market by Product
10.4.6.1.2 South Africa IVD Infectious Diseases Market by Technology
10.4.6.1.3 South Africa IVD Infectious Diseases Market by Application
10.4.6.2 Saudi Arabia IVD Infectious Diseases Market
10.4.6.2.1 Saudi Arabia IVD Infectious Diseases Market by Product
10.4.6.2.2 Saudi Arabia IVD Infectious Diseases Market by Technology
10.4.6.2.3 Saudi Arabia IVD Infectious Diseases Market by Application
10.4.6.3 U.A.E IVD Infectious Diseases Market
10.4.6.3.1 U.A.E IVD Infectious Diseases Market by Product
10.4.6.3.2 U.A.E IVD Infectious Diseases Market by Technology
10.4.6.3.3 U.A.E IVD Infectious Diseases Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America IVD Infectious Diseases Market Overview
10.5.2 South and Central America IVD Infectious Diseases Market Forecasts and Analysis
10.5.3 South and Central America IVD Infectious Diseases Market Forecasts and Analysis - By Product
10.5.4 South and Central America IVD Infectious Diseases Market Forecasts and Analysis - By Technology
10.5.5 South and Central America IVD Infectious Diseases Market Forecasts and Analysis - By Application
10.5.6 South and Central America IVD Infectious Diseases Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil IVD Infectious Diseases Market
10.5.6.1.1 Brazil IVD Infectious Diseases Market by Product
10.5.6.1.2 Brazil IVD Infectious Diseases Market by Technology
10.5.6.1.3 Brazil IVD Infectious Diseases Market by Application
10.5.6.2 Argentina IVD Infectious Diseases Market
10.5.6.2.1 Argentina IVD Infectious Diseases Market by Product
10.5.6.2.2 Argentina IVD Infectious Diseases Market by Technology
10.5.6.2.3 Argentina IVD Infectious Diseases Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. IVD INFECTIOUS DISEASES MARKET, KEY COMPANY PROFILES
12.1. ROCHE DIAGNOSTICS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT LABORATORIES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ALERE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HOLOGIC, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BIO-RAD LABORATORIES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SIEMENS HEALTHCARE
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOMERIUX SA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LUMINEX CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LIFESCAN, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Roche Diagnostics
- Abbott Laboratories
- Alere
- Hologic, Inc
- BD
- Bio-Rad Laboratories
- Siemens Healthcare
- bioMeriux SA
- Luminex Corporation
- LifeScan, Inc